Mumbai (Maharashtra) [India], November 19: Veerhealth Care Limited (BSE: VEERHEALTH), Ayuveer, backed by Veerhealth Care’ sexpertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer its customers an exceptional and safe daily care experience.
Q2 FY25 Standalone Financial Highlights
• Total Income of ₹ 5.39 Cr, YoY growth of 27.14%
• EBITDA of ₹ 0.73 Cr, YoY growth of 16.06%
• EBITDA Margin of 13.55%
• Net Profit of ₹ 0.30 Cr
• Net Profit Margin of 5.54%
Key Highlights For H1 FY25
• Expands U.S.A. Operations with New Export Orders worth around ₹ 0.34 Cr from a leading institutional supplier in the United States of America.
• Manufactured and shipped orders worth approximately ₹ 3.00 Cr
• Secured Export Order Worth around ₹ 0.84 Cr in the Oral Care Category from a Top USA Institutional Supplier
• Expansion and purchase of Additional 27,451 sq. ft. of Land adjacent to its current manufacturing facility to Meet Growing Demand and Enhance Production Capabilities. The new facility will be equipped with plastic blow moulding and injection moulding machines, allowing for backward integration by producing packaging & complementing materials internally.
• Secured Order Worth ₹ 1.21 Cr in the Hair Care Category from a Leading Corporate Healthcare Client.
• Secures Significant Export Order from Top US Institutional Supplier of worth ₹ 0.89 Cr
• Ayuveer’s products have successfully completed the onboarding process on Nykaa’s mobile application and website.
• Secures Significant Export Order from Top US Institutional Supplier of worth ₹ 1.65 Cr
• Secures New order worth ₹ 57.36 Lakhs from a Chain of Retail Indian Healthcare company.
If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.
